10.1016/0891-5849(91)90192-6
10.3109/10715768609051637
10.1161/01.ATV.0000051407.42536.73
10.1016/S1050-1738(01)00094-9
10.1016/0891-5849(89)90015-4
10.1002/(SICI)1097-0231(19990815)13:15<1573::AID-RCM675>3.0.CO;2-Z
10.1016/0021-9673(94)80290-4
10.1093/oxfordjournals.jbchem.a022025
10.1016/S1570-0232(02)00242-8
10.1002/(SICI)1097-0231(19981130)12:22<1665::AID-RCM384>3.0.CO;2-8
10.1007/s11745-002-0941-z
10.1080/10715760500161546
10.1080/10715760600693422
10.1080/0265203031000122012
10.1016/S0891-5849(97)00162-7
10.1183/09031936.04.00002404
10.1016/j.freeradbiomed.2005.08.011
10.1021/bk-2003-0865.ch010
10.1016/j.jchromb.2006.02.038
10.1080/10715760310001636346
10.1016/0014-5793(95)00033-6
10.1016/0076-6879(90)86134-H
10.1016/S1044-0305(02)00911-X
10.1016/S0009-2797(02)00178-3
10.1016/j.freeradbiomed.2006.03.011
Montine KS, 1997, Immunohistochemical detection of 4‐hydroxy‐2‐nonenal adducts in Alzheimer's disease is associated with inheritance of AP OE4, Am J Pathol, 150, 437
10.3109/10715769609149920
10.1111/j.1474-9726.2005.00159.x
10.1016/S0891-5849(99)00117-3
Zivkovic M, 2005, A new method for detection of HNE‐histidine conjugates in rat inflammatory cells, Croatica Chemica Acta, 78, 91
10.1152/ajpheart.1999.276.3.H935
Liu W, 1999, 4‐Hydroxynonenal triggers an epidermal growth‐factor receptor‐linked signal pathway for growth‐inhibition, J Cell Sci, 112, 2409, 10.1242/jcs.112.14.2409
10.1016/S0891-5849(99)00087-8
Wacker M, 2002, Effect of enzyme‐resistant starch on formation of 1,N(2)‐propanodeoxyguanosine adducts of trans‐4‐hydroxy‐2‐nonenal and cell proliferation in the colonic mucosa of healthy volunteers, Cancer Epidemiol Biomarkers Prev, 11, 915
10.1002/(SICI)1099-0801(199902)13:1<75::AID-BMC817>3.0.CO;2-6
10.1016/j.freeradbiomed.2005.05.010
10.1177/002215549804600605
10.1016/j.jpba.2006.01.047
RepettoA BiondiPA ChiesaLM SantanielloE.Synthesis and characterization of 4‐Hydroxynonenal (HNE) derivatives. 3rd International Meeting of the HNE‐Club Genova 16–18 June 2006 abstract n. 27.
10.1016/S0378-4347(96)00446-X
10.1016/S0098-2997(03)00009-8
10.1042/0264-6021:3550237
10.1046/j.1471-4159.1997.69031161.x
10.1016/j.brainres.2004.01.036
10.1016/S0098-2997(03)00011-6
LesgardsJF Des RosiersC.Assay of 4‐hydroxynonenal (HNE) adducts with various polyaminoacids (PAA) using gas chromatography‐mass spectrometry (GCMS). 3rd International Meeting of the HNE‐Club Genova 16–18 June 2006 abstract n. 44.
10.1016/j.jasms.2004.03.013
10.1016/j.bcp.2004.09.006
10.1016/j.freeradbiomed.2004.06.012
10.1016/j.healun.2004.02.021
10.1111/j.1468-1331.2006.01139.x
10.1016/j.freeradbiomed.2004.07.016
10.1046/j.1471-4159.2002.01125.x
10.1016/j.yexmp.2004.10.005
10.1016/j.febslet.2004.11.003
10.1016/j.abb.2005.04.015
10.1016/j.bcp.2006.02.018
10.1089/08977150260139138
10.1016/j.tox.2005.10.012
10.1016/j.taap.2003.10.001
10.1016/S0006-291X(02)02545-7
10.1016/S0021-9258(18)53264-6
10.1016/S0009-2797(97)00096-3
10.1016/S0891-5849(01)00491-9
Szweda LI, 1993, Inactivation of glucose‐6‐phosphate dehydrogenase by 4‐hydroxy‐2‐nonenal. Selective modification of an active site lysine, J Biol Chem, 268, 3342, 10.1016/S0021-9258(18)53699-1
10.1016/j.febslet.2005.12.045
10.1046/j.1471-4159.2001.00451.x
10.1016/S0006-8993(00)02212-5
10.1046/j.1471-4159.1997.68010255.x
10.1016/S0024-3205(03)00661-1
10.1161/01.RES.0000216288.93234.c3
10.1016/j.freeradbiomed.2004.11.005
10.1016/j.freeradbiomed.2004.12.021
10.1016/j.bbabio.2005.06.002
10.1016/S0891-5849(03)00434-9
10.1016/S0891-5849(98)00149-X
10.1194/jlr.M200450-JLR200
10.1016/S0027-5107(03)00012-5
10.1016/j.mrfmmm.2004.01.007
Chung FL, 2000, Deoxyguanosine adducts of t‐4‐hydroxy‐2‐nonenal are endogenous DNA lesions in rodents and humans: Detection and potential sources, Cancer Res, 60, 1507
10.1016/S0027-5107(97)00170-X
10.1016/S0009-2797(01)00259-9
10.1016/j.cbi.2005.09.004
10.1016/S0027-5107(99)00008-1
10.1016/j.freeradbiomed.2004.04.013
10.1093/carcin/23.11.1781
10.1016/S0076-6879(02)53074-3
10.1016/j.neulet.2003.11.047
10.1016/0891-5849(90)90153-A
10.1113/jphysiol.1997.sp021877
10.1016/0891-5849(94)E0093-X
Blasig IE, 1995, 4‐Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium, Amer J Physiol, 269, 14
10.1016/0024-3205(95)02006-5
10.1016/j.neurobiolaging.2005.06.004
10.1016/0014-5793(96)00523-6
10.1111/j.1651-2227.1997.tb08943.x
10.1016/S0378-4347(00)82957-6
10.1080/10715760600592962
10.1080/02652030500164359
10.1158/1055-9965.EPI-06-0085
10.1016/S0168-0102(03)00037-3
10.1097/01.mcg.0000165671.25272.0f
Chowdhury P, 2002, Lipid peroxidation in rat brain is increased by simulated weightlessness and decreased by a soy‐protein diet, Ann Clin Lab Sci, 32, 188
10.1016/j.neuro.2006.08.008
Grune T, 1991, Identification of metabolic pathways of the lipid peroxidation product 4‐hydroxynonenal by enterocytes of rat small intestine, Biochem Int, 25, 963
10.1016/0014-5793(94)00922-8
10.1016/0891-5849(95)00060-B
Siems WG, 1997, Metabolic fate of 4‐hydroxynonenal in hepatocytes: 1,4‐dihydroxynonene is not the main product, J Lipid Res, 38, 612, 10.1016/S0022-2275(20)37269-2
10.1016/0891-5849(90)90564-Y
Schaur RJ, 1991, Membrane lipid peroxidation, 141
10.1007/978-3-0348-9116-5_8
10.1007/978-1-4615-2904-0_3
Grune T, 1994, Metabolism of 4‐hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages, Cancer Res, 54, 5231
10.1016/S0891-5849(96)00496-0
Siems W, 1998, High capacity of secondary antioxidative pathways in thymocytes: Rapid detoxification of 4‐hydroxynonenal, Int J Thymology, 6, 518
10.1016/S0021-9150(01)00454-3
Grune T, 1997, Identification of metabolic pathways of the lipid peroxidation product 4‐hydroxynonenal in in situ perfused rat kidney, J Lipid Res, 38, 1660, 10.1016/S0022-2275(20)37184-4
Chen JJ, 1996, Detoxification of reactive aldehydes in mitochondria: Effects of age and dietary restriction, Aging (Milano), 8, 334
10.1016/0304-3835(89)90208-5
Alary J, 1995, Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4‐hydroxynonenal in the rat, Chem Res Toxicol, 8, 34, 10.1021/tx00043a004
10.1016/S0098-2997(03)00012-8
10.1016/0041-008X(87)90245-6
10.1016/j.atherosclerosis.2003.12.023
10.1016/0167-4838(95)00021-L
10.1080/10715760000301261
10.1096/fasebj.11.7.9212076
10.1016/S0378-4274(99)00301-X
10.1016/S0891-5849(02)00906-1
10.1161/CIRCULATIONAHA.106.630830
10.1158/0008-5472.CAN-06-2105
10.1016/S0009-2797(00)00281-7
10.1016/j.freeradbiomed.2005.04.011
10.1016/j.neures.2006.03.008
10.1016/j.exger.2004.06.015
10.3109/10715769809065811
10.1016/S0891-5849(00)00216-1
10.1016/S0163-7827(03)00014-6
10.1016/S0304-419X(98)00015-8
10.1146/annurev.biochem.69.1.373
10.1016/S0092-8674(02)00966-2
10.1016/S0098-2997(03)00020-7
10.1161/01.ATV.0000164805.73558.80
10.1161/01.ATV.0000043453.21629.3B
10.1016/0891-5849(95)02049-7
10.1523/JNEUROSCI.17-13-05089.1997
10.1016/j.bbamcr.2006.06.003
10.1016/S0006-8993(02)04279-8
10.1111/j.1471-4159.2006.03715.x
10.1126/science.296.5573.1655
10.1111/j.1471-4159.2004.02413.x
10.1152/ajplung.2000.279.3.L429
10.1016/j.bbalip.2005.10.003
10.1016/S0006-291X(02)00512-0
10.1080/00034983.1997.11813168
10.1152/ajpcell.00043.2003
10.1016/S0076-6879(02)52006-1
10.1016/S0891-5849(02)00991-7
10.1016/S0098-2997(03)00017-7
10.1046/j.1471-4159.2000.0740159.x
10.1016/S0009-2797(00)00247-7
10.1046/j.1471-4159.2003.01749.x
10.1046/j.1471-4159.1997.68010255.x
10.1016/S0014-4886(02)00059-6
10.1111/j.1471-4159.2004.02895.x
10.1016/j.freeradbiomed.2006.04.005
10.1161/01.CIR.97.11.1071
10.1016/S0024-3205(01)01166-3
10.1016/j.freeradbiomed.2004.10.031
10.1016/j.freeradbiomed.2005.11.005
10.1016/j.freeradbiomed.2005.03.026
Lee TJ, 2006, Age‐related differential growth rate and response to 4‐hydroxynonenal in mouse aortic smooth muscle cells, Int J Mol Med, 17, 29
10.1016/S0021-9150(02)00198-3
10.1161/01.RES.0000119171.44657.45
10.1016/j.exer.2006.10.020
10.1016/j.freeradbiomed.2007.03.018
10.1016/S0891-5849(02)01082-1
10.1096/fasebj.11.11.9285483
10.1016/S1388-1981(02)00253-6
10.1016/S0168-8278(03)00480-X
Marra F, 1999, Expression of monocyte chemotactic protein‐1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by Vitamin E, J Investig Med, 47, 66
10.1016/0014-4827(91)90416-R
10.1016/S0006-291X(02)00397-2
10.1016/j.freeradbiomed.2004.05.023
10.1016/j.freeradbiomed.2004.10.014
Pizzimenti S, 2005, 4‐Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines, Free Radic Biol Med, 38, 215
10.1096/fasebj.11.2.9039961
10.1152/ajplung.1998.275.5.L861
10.1016/S0098-2997(03)00024-4
10.1046/j.1471-4159.1997.68052092.x
Montine KS, 1997, Immunohistochemical detection of 4‐hydroxy‐2‐nonenal adducts in Alzheimer's disease is associated with inheritance of AP OE4, Am J Pathol, 150, 437
10.1016/S0197-4580(97)00108-5
10.1016/S0197-4580(98)00009-8
10.1016/j.neulet.2005.12.017
10.1016/j.neuint.2005.12.003
10.1016/j.bbadis.2004.06.021
10.1046/j.1471-4159.1997.69020570.x
10.1097/00005072-199803000-00007
10.1046/j.1471-4159.2000.0751234.x
10.1016/j.freeradbiomed.2004.11.005
10.1046/j.1471-4159.1997.69031196.x
10.1097/01.jnen.0000179050.54522.5a
10.1016/S0304-3940(01)02514-9
10.1016/S0891-5849(98)00021-5
10.1007/s00415-004-0348-9
10.1111/j.1365-2990.1994.tb01174.x
10.1111/j.1471-4159.2005.03070.x
10.1111/j.1471-4159.2006.03807.x
10.1016/S0378-3782(01)00247-X
10.1111/j.1750-3639.2001.tb00409.x
Re G, 1997, Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism, Eur J Emerg Med, 4, 5
10.1111/acer.1998.22.s3_part1.145s
10.1111/j.1530-0277.1998.tb03637.x
10.1016/S0891-5849(01)00757-2
10.1046/j.1365-2559.2003.01599.x
10.1016/S0168-8278(02)00073-9
10.1016/S0168-8278(01)00192-1
10.1016/S0022-2143(99)90022-7
10.1016/j.patbio.2004.11.002
10.1161/01.CIR.0000018605.14470.DD
10.1016/j.cardfail.2004.05.005
10.1016/j.ijcard.2003.12.027
10.1097/00063110-199803000-00004
10.1016/0891-5849(89)90113-5
10.1097/00003246-200208000-00018
10.1097/00003246-199602000-00010
10.1016/j.clinthera.2005.11.006
10.1016/j.freeradbiomed.2005.10.040
Siems W, 2002, Oxidative stress in chronic renal failure as a cardiovascular risk factor, Clin Nephrol, 58, S12
Siems W, 2002, Elevated serum concentration of cardiotoxic lipid peroxidation products in chronic renal failure in relation to severity of renal anemia, Clin Nephrol, 58, S20
10.1046/j.1523-1755.2001.059002481.x
10.1152/ajplung.1998.274.1.L8
10.1016/j.freeradbiomed.2006.05.020
Grigolo B, 2003, Enhanced lipid peroxidation in synoviocytes from patients with osteoarthritis, J Rheumatol, 30, 345
10.1016/j.freeradbiomed.2004.11.001
10.1016/S0891-5849(96)00481-9
10.1203/00006450-199607000-00003
Fuchs J, 1993, Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients, Arzneimittelforschung, 43, 1359
10.1016/S0006-291X(02)02849-8
10.1016/S0925-4439(02)00220-X
10.1152/ajpendo.00437.2002
10.1016/S0940-2993(99)80009-8
10.1016/S0891-5849(03)00468-4
10.1016/S0165-0327(03)00135-6
10.1016/S0006-291X(03)00555-2
10.1152/ajplung.00227.2005
10.1152/ajplung.00337.2005
PetersenD CarboneD DoornJ.Hepatocellular targets of 4‐hydroxy‐2‐nonenal modification. 3rd International Meeting of the HNE‐Club Genova 16–18 June 2006 Abstract Vol. abstract no.06.
10.1016/j.exer.2005.11.017
LinD ZhuX SayreLM.Structural characterization of protein adducts generated during non‐enzymatic oxidation of linoleic acid. 3rd International Meeting of the HNE‐Club Genova 16–18 June 2006 Abstract Vol. abstract no.28.
10.1016/j.neuro.2005.05.009
10.1016/j.freeradbiomed.2005.05.002
10.1016/S0304-3940(99)00652-7
Strovsova M, 2005, In vitro oxidative modification of sarcoplasmic reticulum Ca2+‐ATPase from rabbit skeletal muscle, Biologia, 60, 153
10.1016/j.jchromb.2005.02.025
10.1046/j.1471-4159.1999.0722323.x
10.1016/j.brainres.2004.12.027
10.1016/j.freeradbiomed.2004.11.005
10.1016/j.bbagen.2005.12.019
10.1016/0891-5849(93)90051-U
10.1007/s11745-001-0766-9
